NCT00483327View on ClinicalTrials.gov

Management of Atypical Endometrial Hyperplasia and Endometrial Carcinoma Using Megestrol Acetate

PHASE2CompletedINTERVENTIONAL
Enrollment

31

Participants

Timeline

Start Date

June 30, 2007

Primary Completion Date

October 31, 2013

Study Completion Date

October 31, 2013

Conditions
Atypical Endometrial HyperplasiaEndometrial Carcinoma
Interventions
DRUG

Megestrol Acetate

Trial Locations (2)

10016

Bellevue Hospital, New York

NYU Cancer Center, New York

All Listed Sponsors
lead

NYU Langone Health

OTHER

NCT00483327 - Management of Atypical Endometrial Hyperplasia and Endometrial Carcinoma Using Megestrol Acetate | Biotech Hunter | Biotech Hunter